Bio-Rad Laboratories (BIO) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $720.0 million.
- Bio-Rad Laboratories' Income towards Parent Company rose 20058.68% to $720.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $759.9 million, marking a year-over-year increase of 14120.49%. This contributed to the annual value of $759.9 million for FY2025, which is 14120.49% up from last year.
- According to the latest figures from Q4 2025, Bio-Rad Laboratories' Income towards Parent Company is $720.0 million, which was up 20058.68% from -$341.9 million recorded in Q3 2025.
- Bio-Rad Laboratories' Income towards Parent Company's 5-year high stood at $3.9 billion during Q3 2021, with a 5-year trough of -$3.4 billion in Q1 2022.
- Over the past 5 years, Bio-Rad Laboratories' median Income towards Parent Company value was $87.6 million (recorded in 2023), while the average stood at -$54.7 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first crashed by 44451.59% in 2022, then skyrocketed by 51473.6% in 2024.
- Bio-Rad Laboratories' Income towards Parent Company (Quarter) stood at -$1.6 billion in 2021, then skyrocketed by 152.89% to $827.8 million in 2022, then plummeted by 57.75% to $349.7 million in 2023, then plummeted by 304.67% to -$715.8 million in 2024, then surged by 200.59% to $720.0 million in 2025.
- Its Income towards Parent Company was $720.0 million in Q4 2025, compared to -$341.9 million in Q3 2025 and $317.8 million in Q2 2025.